Follow Suzette Matthijsse
Follow Suzette Matthijsse
Make a free account and we’ll email you when they’re booked to speak, or their slides or recordings are posted.
Get an email when they’re booked to speak.
Suzette Matthijsse
Lumanity
I am passionate about accelerating patient access to innovative therapies by shaping evidence, strategy, and cross-functional decision-making across the product lifecycle. With 15 years of experience spanning academia and HEOR consulting, I specialize in guiding pharmaceutical and biotech partners through the evolving EU HTAR landscape from early development to Joint Clinical Assessments since the EU HTAR entered into force in 2022.
3 talks · 1 event
Speaking
2026
-
Nov 8–11
ISPOR Europe 2026 Upcoming
-
Navigating Europe’s New Era of Health Policy Reform: How Will the EU HTA Regulation, Pharmaceutical Legislation Revision, Critical Medicines Act, and Biotech Act Shape Medicines Development and Patient Access?
Moderator
-
First Wave, First Lessons: Multi-Stakeholder Insights from the initial Joint Clinical Assessments Under the European Regulation on Health Technology Assessment
Moderator
-
Preparing Orphan Medicinal Products for JCA: Strengthening the Evidence Package
Moderator
-